S Robin Cohen1,2, Richard Sawatzky3,4, Lara B Russell4,5, Javad Shahidi6, Daren K Heyland7,8, Anne M Gadermann4,9. 1. 1 Departments of Oncology and Medicine, McGill University, Montreal, QC, Canada. 2. 2 Lady Davis Research Institute of the Jewish General Hospital, Montreal, QC, Canada. 3. 3 School of Nursing, Trinity Western University, Langley, BC, Canada. 4. 4 Centre for Health Evaluation and Outcome Sciences, Providence Health Care Research Institute, Vancouver, BC, Canada. 5. 5 School of Nursing, University of Victoria, Victoria, BC, Canada. 6. 6 Eli Lilly and Company, TBD, Indianapolis, IN, USA. 7. 7 Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, ON, Canada. 8. 8 Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada. 9. 9 School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Abstract
BACKGROUND: The McGill Quality of Life Questionnaire has been widely used with people with life-threatening illnesses without modification since its publication in 1996. With use, areas for improvement have emerged; therefore, various minor modifications were tested over time. AIM: To revise the McGill Quality of Life Questionnaire (McGill Quality of Life Questionnaire-Revised) while maintaining or improving its psychometric properties and length, keeping it as close as possible to the McGill Quality of Life Questionnaire to enable reasonable comparison with existing McGill Quality of Life Questionnaire literature. DESIGN: Data sets from eight studies were used (four studies originally used to develop the McGill Quality of Life Questionnaire, two to develop new McGill Quality of Life Questionnaire versions, and two with unrelated purposes). The McGill Quality of Life Questionnaire-Revised was developed using analyses of measurement invariance, confirmatory factor analysis, and calculation of correlations with the McGill Quality of Life Questionnaire's global quality of life item. SETTING/PARTICIPANTS: Data were from 1702 people with life-threatening illnesses recruited from acute and palliative care units, palliative home care services, and oncology and HIV/AIDS outpatient clinics. RESULTS: The McGill Quality of Life Questionnaire-Revised consists of 14 items (plus the global quality of life item). A new Physical subscale was created combining physical symptoms and physical well-being and a new item on physical functioning. The Existential subscale was reduced to four items. The revised Support subscale, renamed Social, focuses more on relationships. The Psychological subscale remains unchanged. Confirmatory factor analysis results provide support for the measurement structure of the McGill Quality of Life Questionnaire-Revised. The overall scale has good internal consistency reliability ( α = 0.94). CONCLUSION: The McGill Quality of Life Questionnaire-Revised improves on and can replace the McGill Quality of Life Questionnaire since it contains improved wording, a somewhat expanded repertoire of concepts with fewer items, and a single subscale for the physical domain, while retaining good psychometric properties.
BACKGROUND: The McGill Quality of Life Questionnaire has been widely used with people with life-threatening illnesses without modification since its publication in 1996. With use, areas for improvement have emerged; therefore, various minor modifications were tested over time. AIM: To revise the McGill Quality of Life Questionnaire (McGill Quality of Life Questionnaire-Revised) while maintaining or improving its psychometric properties and length, keeping it as close as possible to the McGill Quality of Life Questionnaire to enable reasonable comparison with existing McGill Quality of Life Questionnaire literature. DESIGN: Data sets from eight studies were used (four studies originally used to develop the McGill Quality of Life Questionnaire, two to develop new McGill Quality of Life Questionnaire versions, and two with unrelated purposes). The McGill Quality of Life Questionnaire-Revised was developed using analyses of measurement invariance, confirmatory factor analysis, and calculation of correlations with the McGill Quality of Life Questionnaire's global quality of life item. SETTING/PARTICIPANTS: Data were from 1702 people with life-threatening illnesses recruited from acute and palliative care units, palliative home care services, and oncology and HIV/AIDSoutpatient clinics. RESULTS: The McGill Quality of Life Questionnaire-Revised consists of 14 items (plus the global quality of life item). A new Physical subscale was created combining physical symptoms and physical well-being and a new item on physical functioning. The Existential subscale was reduced to four items. The revised Support subscale, renamed Social, focuses more on relationships. The Psychological subscale remains unchanged. Confirmatory factor analysis results provide support for the measurement structure of the McGill Quality of Life Questionnaire-Revised. The overall scale has good internal consistency reliability ( α = 0.94). CONCLUSION: The McGill Quality of Life Questionnaire-Revised improves on and can replace the McGill Quality of Life Questionnaire since it contains improved wording, a somewhat expanded repertoire of concepts with fewer items, and a single subscale for the physical domain, while retaining good psychometric properties.
Entities:
Keywords:
Quality of life; chronic disease; emotional adjustment; end-of-life care; existentialism; family relations; palliative care; psychometrics; spirituality
Authors: Catherine E Mosher; Ekin Secinti; Wei Wu; Deborah A Kashy; Kurt Kroenke; Jonathan B Bricker; Paul R Helft; Anita A Turk; Patrick J Loehrer; Amikar Sehdev; Ahmad A Al-Hader; Victoria L Champion; Shelley A Johns Journal: Palliat Med Date: 2022-05-30 Impact factor: 5.713
Authors: Allison J Applebaum; Laura C Polacek; Leah Walsh; Anne S Reiner; Kathleen Lynch; Stephanie Benvengo; Justin Buthorn; Thomas M Atkinson; Jun J Mao; Katherine S Panageas; Eli L Diamond Journal: Leuk Lymphoma Date: 2020-02-24
Authors: Login S George; Paul K Maciejewski; Andrew S Epstein; Megan Shen; Holly G Prigerson Journal: J Pain Symptom Manage Date: 2019-12-28 Impact factor: 3.612
Authors: Shevaun Nadin; Mohammed Ali Miandad; Mary Lou Kelley; Jill Marcella; Daren K Heyland Journal: Biomed Res Int Date: 2017-06-19 Impact factor: 3.411
Authors: Richard Sawatzky; Esther Laforest; Kara Schick-Makaroff; Kelli Stajduhar; Sheryl Reimer-Kirkham; Marian Krawczyk; Joakim Öhlén; Barbara McLeod; Neil Hilliard; Carolyn Tayler; S Robin Cohen Journal: J Patient Rep Outcomes Date: 2018-08-22
Authors: Kara Schick-Makaroff; Mehri Karimi-Dehkordi; Lena Cuthbertson; Duncan Dixon; S Robin Cohen; Neil Hilliard; Richard Sawatzky Journal: Gerontologist Date: 2021-04-03
Authors: Petra Rantanen; Harvey Max Chochinov; Linda L Emanuel; George Handzo; Diana J Wilkie; Yingwei Yao; George Fitchett Journal: J Pain Symptom Manage Date: 2021-07-29 Impact factor: 3.612